文献速递糖尿病

多重蛋白组学预测2型糖尿病主要心血管事件

Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes.
PubMed 文献 · Diabetologia · 2018-05-24

该研究基于六项前瞻性流行病学研究,在1211例2型糖尿病成人中采用邻近延伸法检测80种循环蛋白,通过发现/复制设计鉴定出8种与主要不良心血管事件(MACE)相关的蛋白,并将多重蛋白组学加入瑞典国家糖尿病登记风险模型,在独立测试样本中将区分度从0.686提高至0.748。

要点

  • 8种蛋白与MACE风险相关,其中4种为新发现。
  • 80蛋白检测加入既定风险模型后,测试样本C统计量从0.686升至0.748。
  • 20蛋白稀疏模型在测试样本中C统计量为0.747。

核心结论

  • 在社区2型糖尿病居民中鉴定出8种MACE风险蛋白生物标志物,其中4种为新发现。
  • 多重蛋白组学与既定风险模型结合可改善MACE风险预测。
  • 多蛋白阵列可能有助于识别心血管事件风险最高的2型糖尿病患者。

研究设计与样本

  • 联合六项前瞻性流行病学研究,纳入30-77岁2型糖尿病个体,采用邻近延伸法检测80种循环蛋白。
  • 采用发现/复制设计,以多变量校正Cox回归鉴定 incident MACE 的生物标志物。
  • 在随机75%训练子样本中使用梯度提升机器学习和lasso正则化Cox回归,在独立25%测试子样本中评估预测改善。

主要发现

  • 1211例2型糖尿病成人(女性32%)中,平均随访6.4±2.3年期间211例发生MACE。
  • 以<5%错误发现率复制了8种蛋白与MACE风险的关联:MMP-12、IL-27a、KIM-1、FGF-23、蛋白S100-A12、TNFR-1、TNFR-2和TRAIL-R2。
  • 将80蛋白检测加入既定风险因素后,独立测试样本的区分度从0.686(95%CI 0.682, 0.689)提高至0.748(95%CI 0.746, 0.751)。
  • 20种添加蛋白的稀疏模型在测试样本中C统计量为0.747(95%CI 0.653, 0.842)。

临床怎么用

  • 作者认为,多蛋白阵列可能有助于识别心血管事件风险最高的2型糖尿病患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Multiplex proteomics could improve understanding and risk prediction of major adverse cardiovascular events (MACE) in type 2 diabetes. This study assessed 80 cardiovascular and inflammatory proteins for biomarker discovery and prediction of MACE in type 2 diabetes. METHODS: We combined data from six prospective epidemiological studies of 30-77-year-old individuals with type 2 diabetes in whom 80 circulating proteins were measured by proximity extension assay. Multivariable-adjusted Cox regression was used in a discovery/replication design to identify biomarkers for incident MACE. We used gradient-boosted machine learning and lasso regularised Cox regression in a random 75% training subsample to assess whether adding proteins to risk factors included in the Swedish National Diabetes Register risk model would improve the prediction of MACE in the separate 25% test subsample. RESULTS: Of 1211 adults with type 2 diabetes (32% women), 211 experienced a MACE over a mean (±SD) of 6.4 ± 2.3 years. We replicated associations (<5% false discovery rate) between risk of MACE and eight proteins: matrix metalloproteinase (MMP)-12, IL-27 subunit α (IL-27a), kidney injury molecule (KIM)-1, fibroblast growth factor (FGF)-23, protein S100-A12, TNF receptor (TNFR)-1, TNFR-2 and TNF-related apoptosis-inducing ligand receptor (TRAIL-R)2. Addition of the 80-protein assay to established risk factors improved discrimination in the separate test sample from 0.686 (95% CI 0.682, 0.689) to 0.748 (95% CI 0.746, 0.751). A sparse model of 20 added proteins achieved a C statistic of 0.747 (95% CI 0.653, 0.842) in the test sample. CONCLUSIONS/INTERPRETATION: We identified eight protein biomarkers, four of which are novel, for risk of MACE in community residents with type 2 diabetes, and found improved risk prediction by combining multiplex proteomics with an established risk model. Multiprotein arrays could be useful in identifying individuals with type 2 diabetes who are at highest risk of a cardiovascular event.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Nowak C, Carlsson AC, Östgren CJ, et al. Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes. Diabetologia. 2018. PMID: 29796748. doi:10.1007/s00125-018-4641-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。